BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 10329046)

  • 1. Inhibin subunit gene expression in ovarian cancer.
    Fuller PJ; Chu S; Jobling T; Mamers P; Healy DL; Burger HG
    Gynecol Oncol; 1999 May; 73(2):273-9. PubMed ID: 10329046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer.
    Zheng W; Luo MP; Welt C; Lambert-Messerlian G; Sung CJ; Zhang Z; Ying SY; Schneyer AL; Lauchlan SC; Felix JC
    Gynecol Oncol; 1998 Apr; 69(1):23-31. PubMed ID: 9570994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression status and mutational analysis of the ras and B-raf genes in ovarian granulosa cell and epithelial tumors.
    Jamieson S; Alexiadis M; Fuller PJ
    Gynecol Oncol; 2004 Dec; 95(3):603-9. PubMed ID: 15581971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of activin, inhibin, and follistatin in epithelial ovarian carcinoma.
    Welt CK; Lambert-Messerlian G; Zheng W; Crowley WF; Schneyer AL
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3720-7. PubMed ID: 9360531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation.
    Di Simone N; Crowley WF; Wang QF; Sluss PM; Schneyer AL
    Endocrinology; 1996 Feb; 137(2):486-94. PubMed ID: 8593793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical localization and mRNA expression of activin, inhibin, follistatin, and activin receptor in bovine cumulus-oocyte complexes during in vitro maturation.
    Izadyar F; Dijkstra G; Van Tol HT; Van den Eijnden-van Raaij AJ; Van den Hurk R; Colenbrander B; Bevers MM
    Mol Reprod Dev; 1998 Feb; 49(2):186-95. PubMed ID: 9444661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibin and activin are demonstrable by immunohistochemistry in ovarian tumor tissue.
    Gurusinghe CJ; Healy DL; Jobling T; Mamers P; Burger HG
    Gynecol Oncol; 1995 Apr; 57(1):27-32. PubMed ID: 7705698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of activin and inhibin subunits, receptors and binding proteins in human pheochromocytomas: a study based on mRNA analysis and immunohistochemistry.
    Hofland J; van Nederveen FH; Timmerman MA; Korpershoek E; de Herder WW; Lenders JW; Verhofstad AA; de Krijger RR; de Jong FH
    Clin Endocrinol (Oxf); 2007 Mar; 66(3):335-40. PubMed ID: 17302865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of inhibin/activin system messenger ribonucleic acids and proteins in ovarian follicles from women with polycystic ovarian syndrome.
    Roberts VJ; Barth S; el-Roeiy A; Yen SS
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1434-9. PubMed ID: 7962340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibin, activin, follistatin, activin receptors and beta-glycan gene expression in the villous tissue of miscarriage patients.
    Muttukrishna S; Bearfield C; Johns J; Jauniaux E
    Mol Hum Reprod; 2004 Nov; 10(11):793-8. PubMed ID: 15361555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in pituitary expression of mRNAs encoding the putative inhibin co-receptor (betaglycan) and type-I and type-II activin receptors during the chicken ovulatory cycle.
    Lovell TM; Knight PG; Gladwell RT
    J Endocrinol; 2005 Sep; 186(3):447-55. PubMed ID: 16135664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seladin-1/DHCR24 expression in normal ovary, ovarian epithelial and granulosa tumours.
    Fuller PJ; Alexiadis M; Jobling T; McNeilage J
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):111-5. PubMed ID: 15963070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of inhibin/activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle.
    Roberts VJ; Barth S; el-Roeiy A; Yen SS
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1402-10. PubMed ID: 8077341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells.
    Steller MD; Shaw TJ; Vanderhyden BC; Ethier JF
    Mol Cancer Res; 2005 Jan; 3(1):50-61. PubMed ID: 15671249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of inhibin/activin subunit messenger ribonucleic acids (mRNAs) by activin A and expression of activin receptor mRNAs in cultured human granulosa-luteal cells.
    Erämaa M; Hildén K; Tuuri T; Ritvos O
    Endocrinology; 1995 Oct; 136(10):4382-9. PubMed ID: 7664658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression pattern of mRNA for follistatin and inhibin/activin beta B-subunit during follicular and testicular development in duck].
    Fu Y; Niu D; Ruan H; Yu XP; Chen G; He GQ; Yang PX
    Yi Chuan Xue Bao; 2001; 28(9):808-15. PubMed ID: 11582738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of activin-beta A subunit mRNA is associated with decreased activin type II receptor mRNA levels in the testes of alpha-inhibin deficient mice.
    Trudeau VL; Matzuk MM; Haché RJ; Renaud LP
    Biochem Biophys Res Commun; 1994 Aug; 203(1):105-12. PubMed ID: 8074643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibin-activin receptor subunit gene expression in ovarian tumors.
    Fuller PJ; Zumpe ET; Chu S; Mamers P; Burger HG
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1395-401. PubMed ID: 11889215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human pituitary adenomas express endogenous inhibin subunit and follistatin messenger ribonucleic acids.
    Alexander JM; Swearingen B; Tindall GT; Klibanski A
    J Clin Endocrinol Metab; 1995 Jan; 80(1):147-52. PubMed ID: 7829603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues.
    van Schaik RH; Wierikx CD; Timmerman MA; Oomen MH; van Weerden WM; van der Kwast TH; van Steenbrugge GJ; de Jong FH
    Br J Cancer; 2000 Jan; 82(1):112-7. PubMed ID: 10638976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.